Identification of nafamostat mesylate as a selective stimulator of NK cell IFN-γ production via metabolism-related compound library screening.

"Declarations Ethics approvalThe studies involving human participants were reviewed and approved by the Institutional Review Board of Hunan Children’s Hospital (authorization number HCHLL-2021–70). Consent for publicationThe authors agree with the publication of this paper. The authors are responsible for the accuracy of the statements provided in the manuscript. Conflict of interestThe authors declare no competing interests. Conflict of interest The authors declare no competing interests."

"Funding This study was supported by funding from the National Key Research and Development Project (nos. 2020YFA0113500 and 2019YFA0111200 to YoD). This study was also supported by the National Natural Science Foundation of China (no. 81900055 to HP; nos. 81922068 and 81874313 to YoD). This study was also supported by funding from the Natural Science Foundation of Hunan Province (no. 2021JJ40274 to HP; no. 2020JJ5279 to YaD; No. 2020JJ5283 to SZ). This work was also supported by funding from the Natural Science Foundation of Changsha (no. kq2014185 to SW). This work was also supported by the Health Commission Foundation of Hunan Province (no. 202102080410 to SZ). This work was also supported by funding from the Science Foundation of Hunan Children’s Hospital (2020 and 2021 to QY)."